News and Trends 9 May 2023
The future of cell and gene therapy in hearing loss
By Nawal Ouzren, CEO of Sensorion Therapeutics for inner ear hearing loss remains an unconquered frontier and the unmet need…
hearing loss
- Latest Posts
Best in Biotech 29 Mar 2023
5 hearing loss biotech companies you should know about
More than 1.5 billion people - nearly 20% of the world’s population - live with hearing loss globally, with 430…
In Depth 28 Mar 2023
Stem cell therapy: a potential cure for hearing loss?
The dawn of the 21st century witnessed the success of the Human Genome Project, the quiver of the Braille glove…
Best in Biotech 23 Mar 2023
Hearing loss research: Five advancements in the past year
At present, more than 1.4 billion people live with hearing loss globally. Hearing disorders are often caused by aging, frequent…
ADVERTISEMENT
News and Trends 31 Jan 2023
Sensorion and EVEON collaborating on injection system to deliver gene therapy inner ear treatments
Sensorion and EVEON are collaborating on the design and development of an injection system for the delivery of Sensorion’s gen…
News and Trends 3 Jan 2023
Sensorion announces first patient enrolled in cisplatin-induced ototoxicity trial
Sensorion has announced that the first patient has been enrolled in its phase 2a proof of concept clinical trial of…
More News! 7 Nov 2022
Sensorion granted rare pediatric disease designation by FDA for lead therapy gene
Sensorion has announced that the US Food and Drug Administration (FDA) has granted rare pediatric disease designation to its lead…
More News! 24 Oct 2022
Sensorion gets go-ahead from France for trial of drug to prevent hearing loss
Biotech company, Sensorion, today (October 24) announced that the initiation of a proof of concept (PoC) clinical trial of SENS-401…
News and Trends 12 Sep 2022
Sensorion receives positive opinion from EMA for treatment of hearing loss
The European Medicines Agency (EMA) through its Committee for Orphan Medicinal Products (COMP) has adopted a positive opinion for a…
News and Trends 22 Jul 2022
Beyond Biotech podcast 6: Mogrify, +ND Capital, Poolbeg Pharma
On this week’s podcast, our guests are Jeremy Skillington, CEO of Poolbeg Pharma; Dani Bach, and Eric Moessinger, both partners…
News and Trends 5 Jul 2022
Mogrify and Astellas to address sensorineural hearing loss
Biopharma company Mogrify Limited, and Japanese regenerative medicine firm Astellas Pharma Inc., have announced a collaborative research agreement on in…
News and Trends 1 Jul 2022
Progress for hearing preservation trial after Australian approval granted
Approval has been granted by the Australian authorities to allow a French company to progress with a clinical trial testing…
